Safety and immunogenicity of synchronous COVID19 and influenza vaccination-Reference-Cited by-同舟云学术

Safety and immunogenicity of synchronous COVID19 and influenza vaccination

Published:2022-08 Issue:3 Volume:2 Page:100082
ISSN:2667-0380
Container-title:Journal of Clinical Virology Plus
language:en
Short-container-title:Journal of Clinical Virology Plus

Author:

Baj Andreina^ORCID,Gasperina Daniela Dalla^ORCID,Focosi Daniele,Forlani Greta,Ferrante Francesca Drago,Novazzi Federica,Azzi Lorenzo,Maggi Fabrizio

Publisher

Elsevier BV

Subject

General Earth and Planetary Sciences,General Engineering,General Environmental Science

Reference7 articles.

1. Antibody titers before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged ≥60 years;Eliakim-Raz;JAMA,2021

2. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study;Barda;Lancet,2021

3. Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2;Levine-Tiefenbrun;Nat. Med.,2021

4. Prevention and control of seasonal Influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2021-22 Influenza Seasonal;Grohskopf;MMWR Recommend. Rep.: Morb. Mortal. Wkly. Rep. Recommend. Rep.,2021

5. LIAISON® SARS-CoV-2 TrimericS IgG assay. Accessed online at https://www.diasorin.com/sites/default/files/allegati_prodotti/liaisonr_sars-cov-2_trimerics_igg_assay_m0870004408_a_lr_0.pdf on November 19, 2021. Accessed.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and safety of concomitant bivalent COVID-19 and quadrivalent influenza vaccination: Implications of immune imprinting and interference;Clinical Microbiology and Infection;2024-01

2. From Co-Administration to Co-Formulation: The Race for New Vaccines against COVID-19 and Other Respiratory Viruses;Vaccines;2023-01-02

3. Concurrent administration of COVID-19 vaccine and seasonal influenza vaccine: Expected rate of adverse effect;Indian Journal of Allergy, Asthma and Immunology;2023

4. Concurrent administration of COVID-19 vaccine and seasonal influenza vaccine: No increased estimated vaccine-related mortality rate;Indian Journal of Pharmacology;2023

5. First SARS-CoV-2 vaccine booster and influenza vaccination: risk assessment of COVID-19 hospitalisation and death;EPIDEMIOL PREV;2022